Clinical Interpretation of Peri‐ERCP Antibiotic Use in Distal Malignant Biliary Obstruction
Journal of Gastroenterology and Hepatology · 2026-06 · 41 (6) · 1897-1898
DOI: 10.1111/jgh.70366 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of Gastroenterology and Hepatology, online erschienen am 23.03.2026. Verfasst von Jiajing Zhao und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary and Pancreas Surgery, Shenzhen People's Hospital, the Second Clinical Medical College, Jinan University, Shenzhen, China. Die Arbeit nennt 7 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hepatobiliary and Pancreas Surgery, Shenzhen People's Hospital, the Second Clinical Medical College, Jinan University, Shenzhen, China.
- Department of Hepatobiliary and Pancreas Surgery, the First Affiliated Hospital (Shenzhen People's Hospital), School of Medicine, Southern University of Science and Technology, Shenzhen, China.
ORCID-Profile: Jiajing Zhao, Liping Liu
Zitieren
APA
Zhao, J., & Liu, L. (2026). Clinical Interpretation of Peri‐ERCP Antibiotic Use in Distal Malignant Biliary Obstruction. Journal of Gastroenterology and Hepatology, 41(6), 1897-1898. https://doi.org/10.1111/jgh.70366
Vancouver
Zhao J, Liu L. Clinical Interpretation of Peri‐ERCP Antibiotic Use in Distal Malignant Biliary Obstruction. Journal of Gastroenterology and Hepatology. 2026;41(6):1897-1898. doi:10.1111/jgh.70366
BibTeX
@article{Zhao2026,
author = {Zhao, Jiajing and Liu, Liping},
title = {Clinical Interpretation of Peri‐ERCP Antibiotic Use in Distal Malignant Biliary Obstruction},
journal = {Journal of Gastroenterology and Hepatology},
year = {2026},
volume = {41},
number = {6},
pages = {1897--1898},
doi = {10.1111/jgh.70366}
}
EUVIMED